002044 美年健康
已收盘 04-30 15:00:00
资讯
新帖
简况
【私募调研记录】健顺投资调研迈威生物、美年健康
证券之星 · 05-01
【私募调研记录】健顺投资调研迈威生物、美年健康
4月30日美年健康跌9.43%,富国新动力灵活配置混合A基金重仓该股
证券之星 · 04-30
4月30日美年健康跌9.43%,富国新动力灵活配置混合A基金重仓该股
图解美年健康一季报:第一季度单季净利润同比减66.67%
证券之星 · 04-30
图解美年健康一季报:第一季度单季净利润同比减66.67%
美年健康(002044.SZ)发一季度业绩,净亏损2.87亿元
智通财经 · 04-29
美年健康(002044.SZ)发一季度业绩,净亏损2.87亿元
国金证券给予美年健康买入评级,量价齐升业绩增长,龙头发展前景可期
每日经济新闻 · 04-25
国金证券给予美年健康买入评级,量价齐升业绩增长,龙头发展前景可期
美年健康(002044.SZ)发布2023年度业绩,净利润5.06亿元,扭亏为盈
智通财经 · 04-24
美年健康(002044.SZ)发布2023年度业绩,净利润5.06亿元,扭亏为盈
美年健康AII IN AI,创新重塑健管行业
新浪财经 · 04-15
美年健康AII IN AI,创新重塑健管行业
美年健康(002044.SZ)发预盈,预计2023年净利润4.6亿元亿元至5.7亿元 同比扭亏为盈
智通财经网 · 01-28
美年健康(002044.SZ)发预盈,预计2023年净利润4.6亿元亿元至5.7亿元 同比扭亏为盈
美年健康(002044.SZ)拟与美因健康签订基因检测项目合作协议
智通财经网 · 01-07
美年健康(002044.SZ)拟与美因健康签订基因检测项目合作协议
美年健康(002044.SZ)向激励对象首次授予6654.22万份股票期权 行权价4.29元/份
智通财经网 · 01-07
美年健康(002044.SZ)向激励对象首次授予6654.22万份股票期权 行权价4.29元/份
美年健康(002044.SZ)拟推7828.5万份股票期权激励计划
智通财经网 · 2023-12-06
美年健康(002044.SZ)拟推7828.5万份股票期权激励计划
美年健康:阿里网络拟向杭州灏月转让公司8.02%股份 总价19.37亿
金融界网站 · 2023-12-03
美年健康:阿里网络拟向杭州灏月转让公司8.02%股份 总价19.37亿
“头”等大事,刻不容缓 ——美年健康“脑睿佳”
新浪财经 · 2023-11-20
“头”等大事,刻不容缓 ——美年健康“脑睿佳”
美年健康脑检产品“脑睿佳”已快速落地200个城市,致力成为阿兹海默症早筛市场的引领者与普及者
新浪证券 · 2023-11-13
美年健康脑检产品“脑睿佳”已快速落地200个城市,致力成为阿兹海默症早筛市场的引领者与普及者
加载更多
公司概况
公司名称:
美年大健康产业控股股份有限公司
所属行业:
卫生
上市日期:
2005-05-18
主营业务:
美年大健康产业控股股份有限公司主营业务为健康体检服务。公司主要提供的服务为体检服务。公司是中国领先的专业健康体检和医疗服务集团,在全国29个省市拥有200余家医疗及体检中心。
发行价格:
3.55
{"stockData":{"symbol":"002044","market":"SZ","secType":"STK","nameCN":"美年健康","latestPrice":4.42,"timestamp":1714460589000,"preClose":4.88,"halted":0,"volume":183992612,"delay":0,"floatShares":3872000000,"shares":3914000000,"eps":0.0987,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.46,"latestTime":"04-30 15:00:00","open":4.74,"high":4.77,"low":4.4,"amount":830000000,"amplitude":0.0758,"askPrice":4.43,"askSize":5020,"bidPrice":4.42,"bidSize":4586,"shortable":0,"etf":0,"ttmEps":0.0987,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":4.88,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":5.37,"lowLimit":4.39,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":3914253923,"pbRate":2.48,"roa":"--","roe":"--","epsLYR":0.13,"committee":0.743259,"marketValue":17301000000,"floatMarketCap":17114000000,"peRate":44.782167,"changeRate":-0.0943,"turnoverRate":0.0475,"status":1},"requestUrl":"/m/hq/s/002044/","defaultTab":"news","newsList":[{"id":"2432554786","title":"【私募调研记录】健顺投资调研迈威生物、美年健康","url":"https://stock-news.laohu8.com/highlight/detail?id=2432554786","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2432554786?lang=zh_cn&edition=full","pubTime":"2024-05-01 08:00","pubTimestamp":1714521643,"startTime":"0","endTime":"0","summary":"根据市场公开信息及4月30日披露的机构调研信息,知名私募健顺投资近期对2家上市公司进行了调研,相关名单如下:1)迈威生物 个股亮点:公司9MW2821是公司研发的一款靶向Nectin-4的ADC型创新药。2)美年健康 个股亮点:健康体检服务:常规体检服务,肿瘤早期筛查服务,体检报告解读;公司引入战投,阿里持有公司股权为8.02%;公司已经将AIGC技术应用在健康体检行业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050108011987c5ab97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050108011987c5ab97&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431398391","title":"4月30日美年健康跌9.43%,富国新动力灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431398391","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431398391?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:21","pubTimestamp":1714465269,"startTime":"0","endTime":"0","summary":"证券之星消息,4月30日美年健康跌9.43%创60日新低,收盘报4.42元,换手率4.75%,成交量183.99万手,成交额8.3亿元。重仓美年健康的前十大公募基金请见下表:该股最近90天内共有3家机构给出评级,买入评级2家,增持评级1家;过去90天内机构目标均价为7.2。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共23家,其中持有数量最多的公募基金为富国新动力灵活配置混合A。该公募基金现任基金经理为于洋。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000033095.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431281706","title":"图解美年健康一季报:第一季度单季净利润同比减66.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431281706","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431281706?lang=zh_cn&edition=full","pubTime":"2024-04-30 02:10","pubTimestamp":1714414237,"startTime":"0","endTime":"0","summary":"证券之星消息,美年健康2024年一季报显示,公司主营收入18.01亿元,同比下降14.91%;归母净利润-2.87亿元,同比下降66.67%;扣非净利润-3.02亿元,同比下降71.58%;负债率56.19%,投资收益-829.84万元,财务费用7450.25万元,毛利率28.04%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000002932.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431983258","title":"美年健康(002044.SZ)发一季度业绩,净亏损2.87亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431983258","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431983258?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:12","pubTimestamp":1714389120,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美年健康(002044.SZ)发布2024年第一季度报告,报告期内公司实现营业收入18.01亿元,同比减少14.91%;归属于上市公司股东的净亏损2.87亿元;归属于上市公司股东扣除非经常性损益净亏损3.02亿元;基本每股亏损0.07元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114693.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430445313","title":"国金证券给予美年健康买入评级,量价齐升业绩增长,龙头发展前景可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2430445313","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430445313?lang=zh_cn&edition=full","pubTime":"2024-04-25 10:58","pubTimestamp":1714013880,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 国金证券04月25日发布研报称,给予美年健康(002044.SZ,最新价:4.57元)买入评级。评级理由主要包括:1)四大品牌协同发展,量价齐升促业绩增长;2)数字化运营赋能发展,布局AI持续创新。风险提示:医疗质量风险;市场竞争加剧风险;客流量恢复不及预期的风险;商誉减值风险;连锁化经营带来的经营管理风险;股票质押风险等。(文章来源:每日经济新闻)\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-25/doc-inasziaa7673462.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-25/doc-inasziaa7673462.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429430932","title":"美年健康(002044.SZ)发布2023年度业绩,净利润5.06亿元,扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2429430932","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429430932?lang=zh_cn&edition=full","pubTime":"2024-04-24 20:18","pubTimestamp":1713961086,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美年健康(002044.SZ)发布2023年年度报告,公司营业收入108.94亿元,同比增长26.44%;归属于上市公司股东的净利润5.06亿元,扭亏为盈;归属于上市公司股东的扣除非经常性损益的净利润4.63亿元,扭亏为盈;基本每股收益0.13元/股。拟向全体股东每10股派发现金红利0.19元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109057.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427060080","title":"美年健康AII IN AI,创新重塑健管行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2427060080","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2427060080?lang=zh_cn&edition=full","pubTime":"2024-04-15 08:00","pubTimestamp":1713139200,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 进入2024年,健康管理领域发生了一件里程碑式的事件。华为云与美年健康、润达医疗三方宣布将充分发挥各自优势,联合打造国内首款健康管理AI机器人。 华为是全球领先的科技公司,而美年健康拥有近2亿的专业健康体检数据及广大应用场景,再加上润达医疗深厚的行业经验,这样的强强联合,会擦出怎样的火花,又会引发哪些行业变革呢?","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/enterprise/2024-04-15/doc-inaruzss4588972.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/2024-04-15/doc-inaruzss4588972.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2406973900","title":"美年健康(002044.SZ)发预盈,预计2023年净利润4.6亿元亿元至5.7亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2406973900","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2406973900?lang=zh_cn&edition=full","pubTime":"2024-01-28 15:59","pubTimestamp":1706428740,"startTime":"0","endTime":"0","summary":"美年健康(002044.SZ)发布2023年年度业绩预告,预计全年归属于上市公司股东的净利润4.6亿元亿元至5.7亿元,同比扭亏为盈。报告期内,公司持续发力以高品质产品与优质服务满足客户需求。预计2023年度营业收入107.3亿元至110.5亿元,同比增幅25.75%-29.50%。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-28/doc-inafamqz5155133.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-28/doc-inafamqz5155133.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2401662934","title":"美年健康(002044.SZ)拟与美因健康签订基因检测项目合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2401662934","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2401662934?lang=zh_cn&edition=full","pubTime":"2024-01-07 16:33","pubTimestamp":1704616380,"startTime":"0","endTime":"0","summary":"美年健康发布公告,公司于2024年1月5日召开第八届董事会第三十一次(临时)会议,审议通过了《关于与美因健康科技(北京)有限公司签署<基因检测项目合作协议>暨关联交易的议案》。根据公司经营需要,拟与美因健康科技(北京)有限公司签署《基因检测项目合作协议》,向公司及下属子公司客户销售美因健康的基因检测产品,美因健康按公司及下属子公司提出的项目产品要求为公司及下属子公司客户提供基因检测服务。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-07/doc-inaasyiz9673721.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-07/doc-inaasyiz9673721.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2401664245","title":"美年健康(002044.SZ)向激励对象首次授予6654.22万份股票期权 行权价4.29元/份","url":"https://stock-news.laohu8.com/highlight/detail?id=2401664245","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2401664245?lang=zh_cn&edition=full","pubTime":"2024-01-07 16:30","pubTimestamp":1704616200,"startTime":"0","endTime":"0","summary":"美年健康(002044.SZ)发布公告,根据《上市公司股权激励管理办法》、公司《2023年股票期权激励计划(草案)》相关规定及公司2023年第七次临时股东大会授权,董事会认为公司2023年股票期权激励计划的首次授予条件已经成就,同意将该激励计划首次授权日确定为2024年1月5日,并同意按4.29元/份的行权价格向符合授予条件的360名激励对象授予6,654.22万份股票期权。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-07/doc-inaasyiu0345151.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-07/doc-inaasyiu0345151.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2389163034","title":"美年健康(002044.SZ)拟推7828.5万份股票期权激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2389163034","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2389163034?lang=zh_cn&edition=full","pubTime":"2023-12-06 20:06","pubTimestamp":1701864360,"startTime":"0","endTime":"0","summary":"美年健康(002044.SZ)披露2023年股票期权激励计划(草案),拟向360名激励对象授予的股票期权数量为7828.5万份,占激励计划草案公告时公司股本总额的2%。其中首次授予6654.22万份,行权价格为4.29元/份。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-06/doc-imzxavcr0130501.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-06/doc-imzxavcr0130501.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2388225239","title":"美年健康:阿里网络拟向杭州灏月转让公司8.02%股份 总价19.37亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2388225239","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2388225239?lang=zh_cn&edition=full","pubTime":"2023-12-03 19:36","pubTimestamp":1701603360,"startTime":"0","endTime":"0","summary":"据悉,阿里网络持有的公司股份全部由分立后新设公司杭州灏月承继,并于2023年11月30日与杭州灏月签署《股份转让协议》,约定阿里网络将其持有的公司8.02%股份转让给杭州灏月。每股转让价格为6.17元,转让价款总额为19.37亿元。据了解,杭州灏月成立于2023年10月24日,注册资本42.62亿美元,经营范围包括一般项目:企业管理;企业管理咨询;信息咨询服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2023-12-03/doc-imzwtxsp8316437.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2023-12-03/doc-imzwtxsp8316437.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2384358330","title":"“头”等大事,刻不容缓 ——美年健康“脑睿佳”","url":"https://stock-news.laohu8.com/highlight/detail?id=2384358330","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2384358330?lang=zh_cn&edition=full","pubTime":"2023-11-20 11:24","pubTimestamp":1700450640,"startTime":"0","endTime":"0","summary":"在中国,健康产业是最令人瞩目的产业之一,这也说明国人对健康的关注越来越多,但是脑健康却时常被忽视。有研究表明,2020年中国阿尔兹海默症诊断市场规模约217.5亿元,预计2025年将增长至260.2亿元,一系列数据警醒我们,大脑健康不容忽视!美年健康集团的专项脑检产品“脑睿佳”,在脑部疾病的提前检查预测方面做出了重大突破。据统计,“脑睿佳”团队今年为10652位客户提供线上问诊/咨询服务,“脑睿佳”可谓是脑体检行业的实力派了!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/tech/2023-11-20/doc-imzvfrzw9596092.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/2023-11-20/doc-imzvfrzw9596092.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2383050157","title":"美年健康脑检产品“脑睿佳”已快速落地200个城市,致力成为阿兹海默症早筛市场的引领者与普及者","url":"https://stock-news.laohu8.com/highlight/detail?id=2383050157","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2383050157?lang=zh_cn&edition=full","pubTime":"2023-11-13 14:07","pubTimestamp":1699855620,"startTime":"0","endTime":"0","summary":"据悉,截至2023年11月10日,美年健康集团已完成了阿兹海默症早期筛查的产品布局,专项脑检产品“脑睿佳“在下属400余家分院落地,覆盖全国200余个城市。深圳、上海、武汉、成都、济南、杭州等地的脑健康专项筛查需求成倍数级增长。业内人士称,上述数据表明,经过三年布局,美年健康集团已成为阿兹海默症等脑部疾病早期筛查的引领者与普及者,有助于在预防关口端实现脑部疾病的早发现、早干预、早治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/enterprise/2023-11-13/doc-imzumynt0646932.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/2023-11-13/doc-imzumynt0646932.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2005-05-18","address":"江苏省南通市崇川区人民东路218号","stockEarnings":[{"period":"1week","weight":-0.0243},{"period":"1month","weight":-0.123},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.2682},{"period":"1year","weight":-0.3695},{"period":"ytd","weight":-0.2646}],"companyName":"美年大健康产业控股股份有限公司","boardCode":"AI0083","perCapita":"33079股","boardName":"卫生","registeredCapital":"391425万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 美年大健康产业控股股份有限公司主营业务为健康体检服务。公司主要提供的服务为体检服务。公司是中国领先的专业健康体检和医疗服务集团,在全国29个省市拥有200余家医疗及体检中心。","serverTime":1714938768049,"listedPrice":3.55,"stockholders":"167174人(较上一季度增加34.57%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美年健康(002044)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美年健康(002044)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美年健康,002044,美年健康股票,美年健康股票老虎,美年健康股票老虎国际,美年健康行情,美年健康股票行情,美年健康股价,美年健康股市,美年健康股票价格,美年健康股票交易,美年健康股票购买,美年健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美年健康(002044)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美年健康(002044)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}